Pediatric Invasive Pneumococcal Disease Spectrum Before Third-Generation Pneumococcal Conjugate Vaccine Implementation.
Corinne Levy, Aude Estivaux, Emmanuelle Varon...
https://pubmed.ncbi.nlm.nih.gov/40492721/Actively Recruiting
Led by Association Clinique Thérapeutique Infantile du val de Marne · Updated on 2026-10-28
3000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the impact of pneumococcal conjugate vaccines, including the 7-valent and 13-valent vaccines, on invasive pneumococcal disease IPD in children and newborns in France. This observational study aims to describe clinical features of IPD, the types of pneumococcus involved, underlying health conditions, and vaccination status among children up to 18 years old. Participants under 18 years old who are hospitalized with IPD will have their clinical data analyzed. This includes risk factors, vaccination history, signs of disease severity, treatments received during hospitalization, biological test results, and the specific location of the infection within the body. There are no study interventions as this is an observational research. During the study, researchers will collect detailed information about each participants hospitalization and clinical course to assess the severity of IPD before discharge. They will also evaluate the effects of vaccination on disease outcomes. The study is expected to continue until 2030, with ongoing data collection from hospital records and laboratory analyses.
CONDITIONS
National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
L
Levy Corinne
B
Bechet Stephane
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Association Clinique Thérapeutique Infantile du val de Marne
Lead Sponsor
Pfizer
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Corinne Levy, Aude Estivaux, Emmanuelle Varon...
https://pubmed.ncbi.nlm.nih.gov/40492721/Association Clinique Thérapeutique Infantile du val de Marne
Lead Sponsor
Pfizer
Collaborating Sponsor